000 01826 a2200565 4500
005 20250518041549.0
264 0 _c20200309
008 202003s 0 0 eng d
022 _a1098-1004
024 7 _a10.1002/humu.23817
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFanis, Pavlos
245 0 0 _aA novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.
_h[electronic resource]
260 _bHuman mutation
_c10 2019
300 _a1768-1780 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAlleles
650 0 4 _aBiomarkers
650 0 4 _aDNA Mutational Analysis
650 0 4 _aErythrocyte Indices
650 0 4 _aFemale
650 0 4 _aFetal Hemoglobin
_xgenetics
650 0 4 _aGenetic Association Studies
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aKruppel-Like Transcription Factors
_xchemistry
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Molecular
650 0 4 _aMutation
650 0 4 _aPedigree
650 0 4 _aPhenotype
650 0 4 _aProtein Conformation
650 0 4 _aSeverity of Illness Index
650 0 4 _aStructure-Activity Relationship
650 0 4 _aSymptom Assessment
650 0 4 _abeta-Globins
_xgenetics
650 0 4 _abeta-Thalassemia
_xblood
700 1 _aKousiappa, Ioanna
700 1 _aPhylactides, Marios
700 1 _aKyrri, Andreani
700 1 _aHadjigavriel, Michael
700 1 _aChristou, Soteroula
700 1 _aSitarou, Maria
700 1 _aKleanthous, Marina
773 0 _tHuman mutation
_gvol. 40
_gno. 10
_gp. 1768-1780
856 4 0 _uhttps://doi.org/10.1002/humu.23817
_zAvailable from publisher's website
999 _c29716966
_d29716966